MODULE 1 GENE THERAPY UNIT
Morris Plains, NJ
Owner: Novartis Pharmaceuticals
Architect: Ewing Cole
Surepath completed a three-year assignment with our long-term client, Novartis, managing their new gene therapy project. This project was critical to Novartis' growth in bio-pharmaceuticals and included state of the art clean rooms. Surepath was responsible for overall project management, coordination, scheduling, and managing equipment validation.